News Updates
More Articles
- Regulatory-Ready AI: Modernization and Compliance Can Co-Exist in Clinical Research
- Patient Engagement (PE) and Patient Experience Data (PED)
- The Importance of Consulting Children and Parents in Clinical Trial Design
- Latin America at Inflection Point: Regulatory Agility, Innovation, and Patient-Centered Systems Redefining Region’s Life Sciences Landscape
- Decentralized Manufacturing: New Horizons for Clinical Trials and Treatments in the UK
Regulatory-Ready AI: Modernization and Compliance Can Co-Exist in Clinical Research
Regulatory-Ready AI: Modernization and Compliance Can Co-Exist in Clinical Research
New guidance from EMA and US FDA make one theme clear: AI must be explainable and traceable—and accountability, lifecycle monitoring, and data provenance are essential requirements—when AI informs regulatory decisions.
×
